Factors Associated With Response to Nivolumab in Renal Cell Carcinoma
A study was conducted to assess factors contributing to response to nivolumab treatment for advanced clear cell renal cell carcinoma.
Home
Chemotherapy Associated With Reduced Risk of Alzheimer Disease in CRC Survivors
A retrospective study was conducted to identify the relationship between Alzheimer disease or other neurocognitive disorders and previous treatment with chemotherapy for colorectal cancer.
Breathlessness Associated With Poor Survival in Malignant Pleural Effusions
Investigators conducted a meta-analysis to determine if breathlessness is associated with shorter survival in patients with malignant pleural effusions.
AlloHCT Following Treatment With PD-1 mAbs Beneficial in Classic Hodgkin Lymphoma
An international, retrospective study was conducted to assess outcomes following alloHCT after PD-1 blockade in Hodgkin lymphoma.
Recommendations From FDA-AACR Workshop to Increase African American Representation in Multiple Myeloma Clinical Trials
A workshop was convened by the US Food and Drug Administration and the American Association for Cancer Research to create recommendations for trial design and later stages of drug development in multiple myeloma.
IMiD-Free Regimen Effective in Relapsed/Refractory Multiple Myeloma
A single-arm, phase 2 trial was conducted to assess response to treatment with carfilzomib plus cyclophosphamide and dexamethasone among patients with relapsed/refractory multiple myeloma.
Youth With Cancer May Need Parental Help When Deciding Sperm Banking
After a cancer diagnosis, male adolescents may be unprepared to make decisions about fertility preservation independently and instead need parental involvement.
Socioeconomics Tied to Cognitive Function in Survivors of Childhood Brain Tumors
Researchers hope their findings could lead to targeted interventions to improve cognitive outcomes in pediatric brain tumor survivors from families with low socioeconomic status.
Dasatinib, Nilotinib Effective Second-Line Therapy for Chronic Myeloid Leukemia
Researchers sought to determine whether dasatinib and nilotinib would be effective second-line therapies for patients with chronic phase CML.
Acute Kidney Injury Seen With Induction Chemotherapy for Acute Myeloid Leukemia
Researchers sought to determine the incidence and risk factors for acute kidney in patients with AML who are undergoing induction chemotherapy.
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Hematologic Cancers
